Drug intelligence / Profile preview

lidocaine hydrochloride + povidone-iodine + triamcinolone

Development stage
Approved
Lead developer
Eugia Pharma Specialities
Modality
Small Molecules
Administration
Intramuscular, Intraarticular, Topical, Percutaneous
01

Overview

**Lidocaine hydrochloride + povidone-iodine + triamcinolone** is a marketed multi-component pharmaceutical kit product sold as **Physician EZ Use Joint Tunnel and Trigger Kit II**. The kit combines **lidocaine hydrochloride**, an amide local anesthetic that blocks voltage-gated sodium channels to produce local or regional anesthesia, **triamcinolone acetonide**, a synthetic glucocorticoid corticosteroid that activates glucocorticoid receptors to suppress inflammation and immune signaling, and **povidone-iodine**, a topical antiseptic used for skin preparation. Based on the provided context, the product is distributed by **AuroMedics Pharma** and manufactured by **Aurobindo Pharma** for **intramuscular** and **intra-articular** administration as part of joint, tunnel, and trigger-point injection procedures; the triamcinolone component carries broad corticosteroid indications across allergic, dermatologic, rheumatic, hematologic, neoplastic, renal, neurologic, ophthalmic, gastrointestinal, endocrine, and respiratory disorders, while lidocaine provides procedural local anesthesia. The product is a small-molecule combination drug rather than a novel molecular entity, and the provided context notes that its labeling has not been approved by the FDA as safe and effective.

Brand names
Physician EZ Use Joint Tunnel and Trigger Kit II
Other names
lidocaine hydrochloride + povidone-iodine + triamcinolone acetonidelidocaine hydrochloride + povidone-iodine + triamcinolone
02

Targets

GR (Glucocorticoid receptor)NaV (Voltage-gated sodium channels)

Beyond the preview

Go deeper on lidocaine hydrochloride + povidone-iodine + triamcinolone.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on lidocaine hydrochloride + povidone-iodine + triamcinolone.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call